HealthcareServices

Pharmaceutical Manufacturing Global Forecast: Market to Scale Up to $923.46 Billion by 2030 at 10% CAGR

March 2, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the pharmaceutical manufacturing market from 2026–2035 with trusted insights from The Business Research Company

By how much is the Pharmaceutical Manufacturing Market expected to grow between 2026 and 2030?

The pharmaceutical manufacturing market size has experienced swift expansion in recent years. It is projected to grow from $572.33 billion in 2025 to $630.77 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 10.2%. The historical growth can be attributed to several factors including the expansion of global drug demand, an increase in chronic disease prevalence, growing investments in manufacturing capacity, advancements in formulation technologies, and the strengthening of regulatory quality standards.

The pharmaceutical manufacturing market is anticipated to experience substantial growth over the next few years. It is projected to expand to $923.47 billion by 2030, achieving a compound annual growth rate (CAGR) of 10.0%. This growth during the forecast period can be attributed to several factors, including increasing investments in smart manufacturing facilities, a rising adoption of advanced biologics production, the expansion of personalized medicine manufacturing, a growing focus on cost-efficient production models, and the increasing integration of digital quality management systems. Significant trends expected during this period involve the increasing adoption of continuous manufacturing technologies, a heightened focus on biologics and biosimilars production, the expansion of advanced quality control systems, growing integration of automation and robotics, and an enhanced emphasis on regulatory compliance.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24375&type=smp

Which Drivers Are Influencing Market Acceleration In The Pharmaceutical Manufacturing Market?

The projected expansion of the pharmaceutical manufacturing market is anticipated due to the rising occurrence of chronic illnesses. These are enduring health conditions characterized by gradual progression and a duration of at least a year, frequently necessitating continuous medical care or restricting daily life. The growing frequency of chronic diseases stems from factors such as increased life expectancy, inactive lifestyles, and poor eating habits, thereby fueling the need for sustained healthcare interventions and preventative health strategies. In the context of chronic diseases, pharmaceutical manufacturing plays a crucial role by guaranteeing a consistent provision of vital drugs, fostering advancements in medication creation, and addressing the escalating requirement for efficacious long-term treatments. As an illustration, data from September 2024, supplied by the National Health Service, a UK-based government department, indicates that 11% of adults aged 35 and older suffer from advanced chronic kidney disease, with its occurrence and intensity escalating with age. Close to 48% of those aged 75 and above are afflicted with some manifestation of the condition, while 36% experience more advanced forms. Consequently, the expanding incidence of chronic illnesses is stimulating growth within the pharmaceutical manufacturing market.

What Segments Are Identified Within The Structure Of The Pharmaceutical Manufacturing Market?

The pharmaceutical manufacturing market covered in this report is segmented –

1) By Molecule Type: Biologics And Biosimilars, Conventional Drugs

2) By Formulation: Tablets, Capsules, Injectable, Sprays, Suspensions, Powders, Other Formulations

3) By Route Of Administration: Oral, Topical, Parenteral, Inhalations, Other Route Of Administrations

4) By Therapy Area: Cardiovascular Diseases (CVDs), Pain, Diabetes, Cancer, Respiratory Diseases, Other Diseases

5) By Sales Channel: Retail, Non-retail

Subsegments:

1) By Biologics And Biosimilars: Monoclonal Antibodies, Vaccines, Recombinant Proteins, Cell Therapies, Gene Therapies, Hormones, Blood And Plasma Products

2) By Conventional Drugs: Analgesics, Antipyretics, Antibiotics, Antivirals, Antifungals, Antihypertensives, Antidepressants, Antidiabetics

How Are New Market Trends Shaping The Landscape Of The Pharmaceutical Manufacturing Market?

Leading pharmaceutical manufacturing companies are prioritizing the creation of advanced solutions, such as fully automated radioligand therapy (RLT) manufacturing facilities. This focus aims to boost production efficiency, maintain high-quality standards, and address the growing requirement for targeted cancer treatments. An automated RLT manufacturing facility is a cutting-edge production site that utilizes sophisticated automation technologies to streamline and optimize the manufacture of radioligand therapies, thereby ensuring consistent, efficient, and scalable production. For example, in January 2024, Novartis AG, a pharmaceutical corporation based in Switzerland, obtained US Food and Drug Administration (FDA) approval for Pluvicto production at its state-of-the-art radioligand therapy (RLT) manufacturing facility in Indianapolis. This development will significantly expand the production capacity for its radioligand therapy medicines, including Pluvicto and Lutathera. This strategic expansion is part of Novartis’ wider initiative to meet the increasing worldwide demand for targeted cancer therapies and enhance patient access globally.

Which Key Players Are Driving Competition In The Pharmaceutical Manufacturing Market?

Major companies operating in the pharmaceutical manufacturing market are Pfizer Inc., Johnson & Johnson Services Inc., F. Hoffmann-La Roche Ltd., Merck & Co. Inc., AbbVie Inc., Sanofi SA, Bristol Myers Squibb Company, AstraZeneca plc, Abbott Laboratories, Novartis AG, GlaxoSmithKline plc, Takeda Pharmaceuticals Inc., Eli Lilly and Company, Gilead Sciences Inc., Novo Nordisk A/S, Lonza Group AG, Sun Pharmaceutical Industries Ltd., Dr. Reddy’s Laboratories, Cipla Limited, Samsung Biologics, FUJIFILM Diosynth Biotechnologies U.S.A. Inc., Lupin Limited, Jubilant Pharmova Limited.

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/pharmaceutical-manufacturing-global-market-report

Which Region Is Projected To Lead The Pharmaceutical Manufacturing Market During The Forecast Period?

North America was the largest region in the pharmaceutical manufacturing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pharmaceutical manufacturing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Pharmaceutical Manufacturing Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=24375&type=smp

Browse Through More Reports Similar to the Global Pharmaceutical Manufacturing Market 2026, By The Business Research Company

Pharmaceutical Chemicals Market Report 2026

https://www.thebusinessresearchcompany.com/report/pharmaceutical-chemicals-global-market-report

Pharmaceuticals Market 2026

https://www.thebusinessresearchcompany.com/report/pharmaceuticals-market

Pharmaceutical Logistics Market Report 2026

https://www.thebusinessresearchcompany.com/report/pharmaceutical-logistics-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795